SEC Filing Details

Document Details

Form

Filing Date

Mar 21, 2023

Document Date

Apr 11, 2022

Form Description

Statement of changes in beneficial ownership of securities

Filing Group

3,4,5

Company

MaxCyte Inc

Issuer

MAXCYTE, INC.

Filer

SUMEN CENK

View HTML

ATx

From small to medium static Electroporation.

STx

Transfect up to 20 billion cells with scalable static or flow-through electroporation.

GTx

Transfect up to 20 billion cells with our clinically validated and cGMP compliant flow-through electroporation.

VLx

For gram scale protein production.

Processing Assemblies

Achieve the desired scale and throughput with a range of consumable devices.

Reagents & Supporting Products

Complement your workflow with our flexible electroporation buffer formats and accessories.